Literature DB >> 1968879

Medical management of Crohn's disease.

S Meyers1, D B Sachar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1968879

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN： 0172-6390


× No keyword cloud information.
  3 in total

1.  Switch from systemic steroids to budesonide in steroid dependent patients with inactive Crohn's disease.

Authors:  A Cortot; J F Colombel; P Rutgeerts; K Lauritsen; H Malchow; J Hämling; T Winter; T Persson; E Pettersson
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Oral budesonide is as effective as oral prednisolone in active Crohn's disease. The Global Budesonide Study Group.

Authors:  M Campieri; A Ferguson; W Doe; T Persson; L G Nilsson
Journal:  Gut       Date:  1997-08       Impact factor: 23.059

3.  Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study.

Authors:  R Löfberg; P Rutgeerts; H Malchow; C Lamers; A Danielsson; G Olaison; D Jewell; O Ostergaard Thomsen; H Lorenz-Meyer; H Goebell; H Hodgson; T Persson; C Seidegård
Journal:  Gut       Date:  1996-07       Impact factor: 23.059
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.